WNT signalling in prostate cancer
V Murillo-Garzón, R Kypta - Nature Reviews Urology, 2017 - nature.com
Genome sequencing and gene expression analyses of prostate tumours have highlighted
the potential importance of genetic and epigenetic changes observed in WNT signalling …
the potential importance of genetic and epigenetic changes observed in WNT signalling …
[HTML][HTML] Understanding and targeting prostate cancer cell heterogeneity and plasticity
DG Tang - Seminars in cancer biology, 2022 - Elsevier
Prostate cancer (PCa) is a prevalent malignancy that occurs primarily in old males. Prostate
tumors in different patients manifest significant inter-patient heterogeneity with respect to …
tumors in different patients manifest significant inter-patient heterogeneity with respect to …
Cancer stem cells: regulation programs, immunological properties and immunotherapy
It is becoming increasingly clear that virtually all types of human cancers harbor a small
population of stem-like cancer cells (ie, cancer stem cells, CSCs). These CSCs preexist in …
population of stem-like cancer cells (ie, cancer stem cells, CSCs). These CSCs preexist in …
[HTML][HTML] Androgen receptor-dependent and-independent mechanisms driving prostate cancer progression: Opportunities for therapeutic targeting from multiple angles
DT Hoang, KA Iczkowski, D Kilari, W See… - …, 2016 - pmc.ncbi.nlm.nih.gov
Despite aggressive treatment for localized cancer, prostate cancer (PC) remains a leading
cause of cancer-related death for American men due to a subset of patients progressing to …
cause of cancer-related death for American men due to a subset of patients progressing to …
Slow-cycling (dormant) cancer cells in therapy resistance, cancer relapse and metastasis
It is increasingly appreciated that cancer cell heterogeneity and plasticity constitute major
barriers to effective clinical treatments and long-term therapeutic efficacy. Research in the …
barriers to effective clinical treatments and long-term therapeutic efficacy. Research in the …
[HTML][HTML] Prostate cancer stem cells: the role of androgen and estrogen receptors
E Di Zazzo, G Galasso, P Giovannelli… - …, 2015 - pmc.ncbi.nlm.nih.gov
Prostate cancer is one of the most commonly diagnosed cancers in men, and androgen
deprivation therapy still represents the primary treatment for prostate cancer patients. This …
deprivation therapy still represents the primary treatment for prostate cancer patients. This …
The ins and outs of iron homeostasis
A Donovan, CN Roy, NC Andrews - Physiology, 2006 - journals.physiology.org
Iron is an essential element that is toxic when it accumulates in excess. Intricate regulatory
mechanisms have evolved to maintain iron homeostasis within cells and between different …
mechanisms have evolved to maintain iron homeostasis within cells and between different …
Cancer stem cells in prostate cancer: implications for targeted therapy
R Leão, C Domingos, A Figueiredo, R Hamilton… - Urologia …, 2017 - karger.com
Prostate cancer (PCa) is the most frequently diagnosed cancer in men and the second most
common cause of cancer-related mortality among men in the developed world …
common cause of cancer-related mortality among men in the developed world …
CD133 antibody targeted delivery of gold nanostars loading IR820 and docetaxel for multimodal imaging and near-infrared photodynamic/photothermal …
H Tan, N Hou, Y Liu, B Liu, W Cao, D Zheng… - … , Biology and Medicine, 2020 - Elsevier
Due to the lack of effective strategies on the treatment of castration resistant prostate cancer
(CRPC), we established a multifunctional nanoplatform (GNS@ IR820/DTX-CD133) for the …
(CRPC), we established a multifunctional nanoplatform (GNS@ IR820/DTX-CD133) for the …
Defining a population of stem-like human prostate cancer cells that can generate and propagate castration-resistant prostate cancer
Purpose: We have shown that the phenotypically undifferentiated (PSA−/lo) prostate cancer
cell population harbors long-term self-renewing cancer stem cells (CSC) that resist …
cell population harbors long-term self-renewing cancer stem cells (CSC) that resist …